Children with an immunocompromising condition should be revaccinated once with PPSV23 5 years after the first dose. Heparin
If you ever need to receive a booster dose, you will need to tell your doctor if the previous shot caused any side effects.Becoming infected with pneumococcal disease (such as pneumonia or meningitis) is much more dangerous to your health than receiving this vaccine. Before receiving this vaccine, tell your doctor if you have received a pneumococcal vaccine within the past 3 to 5 years.Since PPSV is usually given only one time, you will most likely not be on a dosing schedule. Follow
For children younger than 2 years old, another vaccine called Like any vaccine, PPSV may not provide protection from disease in every person.PPSV should be given at least 2 weeks before the start of any treatment that can weaken your immune system. Immunization
Follow
Please confirm that you are a health care professionalThe link you have selected will take you to a third-party website.
In the case of a more severe illness with a fever or any type of infection, wait until you get better before receiving this vaccine.Vaccines may be harmful to an unborn baby and generally should not be given to a pregnant woman. This is the Professional Version.
PPSV works by exposing you to a small dose of the bacteria or a protein from the bacteria, which causes your body to develop immunity to the disease. View All News >
Call your doctor for medical advice about side effects.
Follow your doctor's instructions.Your doctor may recommend treating fever and pain with an Most people receive only one PPSV shot during their lifetime. If they have been given PPSV23 but not PCV13, they are given a dose of PCV13 ≥ 1 year after the last dose of PPSV23.People with asymptomatic or symptomatic HIV infection should be vaccinated as soon as possible after their diagnosis.Adults aged 19 to 64 years at highest risk of pneumococcal disease (eg, with functional or anatomic asplenia, chronic kidney disease, or another immunocompromising condition, including cancer and use of corticosteroids) should be given a 2nd dose of PPSV23 5 years after the first PPSV23 dose.All people should be vaccinated with PPSV23 at age 65. Albuterol
Pneumococcal vaccine polyvalent (PPSV23) is indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine Recommendations for Pneumococcal Vaccines Use in Children and Teens Keywords: recommendations for pneumococcal vaccines use in children and teens, risk factors for administering pneumococcal vaccines to children and teens, how to determine which pneumococcal vaccine is needed for children and teens, p2016 Created Date: 10/23/2018 1:47:06 PM
Michigan Department of Health and Human Services-Division of Immunization Page 1 of 2 .
b.
People should be not be vaccinated during chemotherapy or radiation therapy.Adverse effects are usually mild and include fever, irritability, drowsiness, anorexia, vomiting, and local pain and erythema.The trusted provider of medical information since 1899
The 2nd dose is given 5 years after the first (eg, at age 69 if the previous dose was given at age 64). Interruption of the vaccination schedule does not require starting the entire series over or giving extra doses.Children at high risk of pneumococcal disease (eg, children with sickle cell disease, asplenia, or a chronic disorder) should be given a dose of PPSV23 at age 24 months at least 8 weeks after the most recent dose of PCV13.Children aged 14 to 59 months who have received a complete age-appropriate series of PCV7 should be given a single supplemental dose of PCV13.If children aged 6 to 18 years with an immunocompromising condition, a cochlear implant, or a cerebrospinal fluid leak have not been vaccinated with PCV13 or PPSV23, they should be given 1 dose of PCV13, followed by 1 dose of PPSV23 ≥ 8 weeks later. Additional criteria for people aged 2 to 64 years include the following:Chronic cardiovascular disorders (excluding hypertension)PPSV23 is no longer recommended for routine use in American Indians and Alaska natives < 65 years unless they have a medical condition or other indication for PPSV23. Those who are given PPSV23 at or after age 65 should be given only 1 dose.If elective splenectomy is planned, PCV13 should be given ≥ 12 weeks before surgery, followed by a dose of PPSV23 ≥ 8 weeks after PCV13 is given. Live-attenuated vaccines (MMR and VAR) can be given the same day but if not given the same day, they should be separated by at least 4 weeks. Children at high risk of pneumococcal disease (eg, children with sickle cell disease, asplenia, or a chronic disorder) should be given a dose of PPSV23 at age 24 months at least 8 weeks after the most recent dose of PCV13.
Pneumococcal bacteria can infect the sinuses and inner ear. If they have been vaccinated with PPSV23 but not PCV13, they are given 1 dose of PCV13 ≥ 8 weeks after the last dose of PPSV23.
Follow
Tell your doctor about all medications you use.